!!!Jacques Neefjes
[{Image src='neefjes_jacques_small.jpg'  alt='Jacques Neefjes' height='200'}]
Homepage:%%(margin-left:23px;) %%
\\ \\
\\ \\
__Present and Previous Positions__
* since 2009 Head Division of Cell Biology II, the Netherlands Cancer Institute,  Amsterdam 
* since 1999 Extraordinary professor at the LUMC chair of “Antigen Presentation and Processing”
* 2007 - 2011      Deputy Scientific Director, the Netherlands Cancer Institute, Amsterdam
* 2009 - 2011      Visiting professor at the Centre for Immune Regulation of the    University of Oslo, Norway
* 1998 - 2008      Head Division of Tumor Biology, the Netherlands Cancer Institute, Amsterdam
* 2000 - 2003       Dean Graduate School Oncology Amsterdam (OOA)
* 1993 - 1997       Staff member, Division of Cellular Biochemistry, the Netherlands Cancer Institute, Amsterdam
* 1992 - 1993       EMBO long-term fellowship at the Deutsche Krebs Forschungs Zentrum (DKFZ), Heidelberg
* 1991 - 1992       Visiting scientist at the laboratory of Drs C Benoit and D Mathis at the Institut de Chimie Biologique, Strasbourg Fr
__Fields of Scholarship__
* Cell Biology: identified MHC class I and MHC class II cell biology, dynein motor control of vesicles, PI3kinase in MVB biogeneses
* Immunology: Mechanisms of control of MHC class I and MHC class II expression, bacterial control phagosomes
* Chemical Biology: developed reciprocal chemical genetics to find host targets controlling bacterial infections and lead structures
* Cancer: utilizing biophysics showed conformational changes estrogen receptor and deciphered new resistance mechanism
* Biophysics: Neefjes developed various technologies to measure FRET and FRAP for single cell biochemistry.
* Chemistry: Neefjes applies chemistry in cell biology. Generated first inhibitors for TAP and for host factor antibiotics
* Molecular Medicine: Neefjes applied cell biology and next generation sequencing to find new modes of actions of anticancer drug
* Systems Biology: Neefjes has performed integrated screens to generate new biology that was experimentally validated
* High throughput screenings: Neefjes performed various genetic and chemical screens to successfully find new targets and leads
__Honours and Awards__
* 2011 Recipient ERC Advanced Grant
* 2010 Elected member European Academy of Cancer Sciences
* 2006  Elected member EMBO
* 1996  Recipient NWO Pioneer Grant
* 1996  Golden Medal of the Royal Dutch Chemical Society KNCV
* 1992 EMBO long term fellowship
* 1990 Antoni van Leeuwenhoek Award
* Honorary Lectures
** 2012 Ruysch lecture AMC, Amsterdam
** 2012 Beatty Lecturer, McGill University, Montreal, Canada

[{Image src='User/paper_content_pencil_48.png' width='48px' class='image_left'}]
[Curriculum Vitae |User/Neefjes_Jacques/CV]
[{Image src='User/book_48.png' class='image_left'}]
[Publication list|User/Neefjes_Jacques/Publications]
[{Image src='User/camera_noflash_48.png' width='48px' class='image_left'}]
[Highlights of my work and anecdotes|User/Neefjes_Jacques/Highlight]
[{Image src='User/database_48.png' class='image_left'}]
[Other information|User/Neefjes_Jacques/OtherInformation]

[{ALLOW view All}]
[{ALLOW edit jneefjes}]
[{ALLOW upload jneefjes}]
[{ALLOW comment All}]